PERSONAL INFORMATION
Name: Li Ling
Gender: Female
Title: Professor
CONTACT INFORMATION
Email: liling@cqmu.edu.cn
Phone: +86-23-68485240
EDUCATION EXPERIENCE
1979.9-1983.6：BS, Chemistry, Chongqing University
1993.9-1996.6：MS, Chemistry, Chongqing University
WORKING EXPERIENCE
2007.07 to present , Professor, College of Laboratory Medicine, Chongqing Medical University
2002.10-2007.06, Associate Professor, College of Laboratory Medicine, Chongqing Medical University
2002.02-2002.09, Instructor, College of Laboratory Medicine, Chongqing Medical University
2001.02-2002.01, Research Associate, Temple University, General Clinical Research Center,
2000.05-2001.01, Research Associate, Asta Tech, Inc., Lab for Pharm Metab Res
RESEARCH INTERESTS
The main research directions are gene diagnosis and treatment of diabetes and its complications, glucose and lipid metabolism disorders and insulin resistance, and the application of adipocytokines in the diagnosis and treatment of diabetes and obesity.
HONOUR & AWARDS
1. The pathogenesis and clinical research of chronic complications of diabetes, the first prize of Sichuan Provincial Science and Technology Progress Award, 3/9,2013
2. Research and clinical application of adipokines on the regulation of glucose and lipid metabolism and insulin resistance in type 2 diabetes, the third prize of Guizhou Provincial Science and Technology Progress Award, 2/5,2019
3. The pathogenesis and clinical features of chronic complications of diabetes, Third Prize of the Science and Technology Progress Award of the Chinese Medical Association, 2/8, 2015
PUBLICATIONS
1. Li L et al. Central Sfrp5 regulates hepatic glucose flux and VLDL-triglyceride secretion. Metabolism-clinical and experimental, 2020 Feb;103:154029
2. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway. Diabetes 2019; 68(10):1902-1914
3. Ultrasensitive aptasensor for isolation and detection of circulating tumor cells based on CeO2@Ir nanorods and DNA walker. Biosens Bioelectron 2020 Nov 15;168:112516
4. JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism.Cell Death Dis. 2018 Aug 28;9(9):859
5. Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism.FASEB J. 2019; 33(9):10077-10088
